Aug 29, 2024

Hey there, healthcare enthusiasts! I’m here with some exciting news from the medical world. Malaysia’s medical device market is projected to grow to a value of $3.3 billion by 2028, showing a rise at 7.8% CAGR in US dollar terms. This growth is attributed to the increasing demand for wireless enteral feeding devices and the high prevalence of chronic sinusitis, which is driving the expansion of sinus dilation devices market. In addition, the Osteoporosis market is expected to reach $17.9 billion by 2033, due to the increasing adoption of expensive anabolic therapies.

On the other hand, a recent investigation by STAT revealed how UnitedHealth Group’s physician empire did not live up to its promises, affecting the care that patients could receive. However, there’s some positive news from the CDC, as they announced a $118.5 million investment to investigate and prevent pregnancy-related deaths, addressing the maternal mortality crisis in the US.

In other news, Pfizer has joined the direct-to-consumer drug sales market, launching a digital platform for people with migraines and respiratory ailments, including COVID-19, offering virtual appointments with clinicians and home delivery of prescription drugs. This move is expected to stir up more business for Pfizer drugs, providing patients with easier access to medications. And in Massachusetts, a new law aims to integrate midwifery into the healthcare sector, elevating midwives and doulas while reducing the chances of childbirth turning deadly.

Overall, it’s an exciting time in the healthcare industry, with advancements in medical devices, initiatives to address maternal mortality, and new opportunities for direct-to-consumer drug sales. Stay tuned for more updates on the latest developments in the healthcare world!

Summy

Stay Well!